331 related articles for article (PubMed ID: 18617556)
1. Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus.
Zhang HY; Zhang X; Chen X; Thomas D; Hormi-Carver K; Elder F; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G470-8. PubMed ID: 18617556
[TBL] [Abstract][Full Text] [Related]
2. Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus.
Souza RF; Shewmake KL; Shen Y; Ramirez RD; Bullock JS; Hladik CL; Lee EL; Terada LS; Spechler SJ
Am J Gastroenterol; 2005 Mar; 100(3):551-9. PubMed ID: 15743351
[TBL] [Abstract][Full Text] [Related]
3. Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus.
Huo X; Zhang HY; Zhang XI; Lynch JP; Strauch ED; Wang JY; Melton SD; Genta RM; Wang DH; Spechler SJ; Souza RF
Gastroenterology; 2010 Jul; 139(1):194-203.e1. PubMed ID: 20303354
[TBL] [Abstract][Full Text] [Related]
4. Barrett's metaplasia develops from cellular reprograming of esophageal squamous epithelium due to gastroesophageal reflux.
Minacapelli CD; Bajpai M; Geng X; Cheng CL; Chouthai AA; Souza R; Spechler SJ; Das KM
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G615-G622. PubMed ID: 28336546
[TBL] [Abstract][Full Text] [Related]
5. In Barrett's epithelial cells, weakly acidic bile salt solutions cause oxidative DNA damage with response and repair mediated by p38.
Huo X; Dunbar KB; Zhang X; Zhang Q; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G464-G478. PubMed ID: 31984785
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines.
Feagins LA; Zhang HY; Zhang X; Hormi-Carver K; Thomas T; Terada LS; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G411-7. PubMed ID: 18063706
[TBL] [Abstract][Full Text] [Related]
7. Activity of mitogen-activated protein kinases in the esophageal epithelium of patients with Barrett's esophagus.
Chwiesko A; Baniukiewicz A; Semeniuk J; Kaczmarski M; Wasielica-Berger J; Milewski R; Dabrowski A
Dis Esophagus; 2015; 28(6):585-92. PubMed ID: 24867362
[TBL] [Abstract][Full Text] [Related]
8. Acid has antiproliferative effects in nonneoplastic Barrett's epithelial cells.
Feagins LA; Zhang HY; Hormi-Carver K; Quinones MH; Thomas D; Zhang X; Terada LS; Spechler SJ; Ramirez RD; Souza RF
Am J Gastroenterol; 2007 Jan; 102(1):10-20. PubMed ID: 17266684
[TBL] [Abstract][Full Text] [Related]
9. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus.
Souza RF; Shewmake K; Terada LS; Spechler SJ
Gastroenterology; 2002 Feb; 122(2):299-307. PubMed ID: 11832445
[TBL] [Abstract][Full Text] [Related]
10. In non-neoplastic Barrett's epithelial cells, acid exerts early antiproliferative effects through activation of the Chk2 pathway.
Zhang HY; Zhang X; Hormi-Carver K; Feagins LA; Spechler SJ; Souza RF
Cancer Res; 2007 Sep; 67(18):8580-7. PubMed ID: 17875697
[TBL] [Abstract][Full Text] [Related]
11. The biopsy diagnosis of gastroesophageal reflux disease, "carditis," and Barrett's esophagus, and sequelae of therapy.
Riddell RH
Am J Surg Pathol; 1996; 20 Suppl 1():S31-50. PubMed ID: 8694147
[TBL] [Abstract][Full Text] [Related]
12. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia.
Inge LJ; Fowler AJ; Paquette KM; Richer AL; Tran N; Bremner RM
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):531-8. PubMed ID: 23142123
[TBL] [Abstract][Full Text] [Related]
13. Symptoms, acid exposure and motility in patients with Barrett's esophagus.
Brandt MG; Darling GE; Miller L
Can J Surg; 2004 Feb; 47(1):47-51. PubMed ID: 14997925
[TBL] [Abstract][Full Text] [Related]
14. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of Barrett's esophagus.
Chandrasoma P
Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):270-8. PubMed ID: 9263345
[TBL] [Abstract][Full Text] [Related]
16. Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.
Zhang HY; Zhang Q; Zhang X; Yu C; Huo X; Cheng E; Wang DH; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G454-60. PubMed ID: 21148399
[TBL] [Abstract][Full Text] [Related]
17. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
DE Carli DM; Araujo AF; Fagundes RB
Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
[TBL] [Abstract][Full Text] [Related]
18. Short segment Barrett's esophagus and distal gastric intestinal metaplasia.
Dietz J; Chaves-E-Silva S; Meurer L; Sekine S; de Souza AR; Meine GC
Arq Gastroenterol; 2006; 43(2):117-20. PubMed ID: 17119666
[TBL] [Abstract][Full Text] [Related]
19. A human Barrett's esophagus organoid system reveals epithelial-mesenchymal plasticity induced by acid and bile salts.
Zhang Q; Bansal A; Dunbar KB; Chang Y; Zhang J; Balaji U; Gu J; Zhang X; Podgaetz E; Pan Z; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2022 Jun; 322(6):G598-G614. PubMed ID: 35380457
[TBL] [Abstract][Full Text] [Related]
20. Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line.
Jaiswal K; Lopez-Guzman C; Souza RF; Spechler SJ; Sarosi GA
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G335-42. PubMed ID: 16239404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
